Molecular Diagnostics Infectious Disease Testing Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: M18BEEBC8473EN
Market Monitor Global

Abstracts

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.

This report contains market size and forecasts of Molecular Diagnostics Infectious Disease Testing in Global, including the following market information:

Global Molecular Diagnostics Infectious Disease Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Molecular Diagnostics Infectious Disease Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bacterial Infectious Disease Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Molecular Diagnostics Infectious Disease Testing include Abbott Laboratories, BD, bioM?rieux, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens AG, Veridex, Luminex and GenMark Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Diagnostics Infectious Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Molecular Diagnostics Infectious Disease Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Molecular Diagnostics Infectious Disease Testing Market Segment Percentages, by Type, 2021 (%)

• Bacterial Infectious Disease Testing
• Viral Infectious Disease Testing
• Parasitic Infectious Disease Testing

Global Molecular Diagnostics Infectious Disease Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Molecular Diagnostics Infectious Disease Testing Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Laboratory Research

Global Molecular Diagnostics Infectious Disease Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Molecular Diagnostics Infectious Disease Testing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Molecular Diagnostics Infectious Disease Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Molecular Diagnostics Infectious Disease Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• BD
• bioM?rieux
• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Siemens AG
• Veridex
• Luminex
• GenMark Diagnostics
• Qiagen NV
• Genomix Biotech
• BioTheranostics
• GenMark Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Molecular Diagnostics Infectious Disease Testing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Molecular Diagnostics Infectious Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING OVERALL MARKET SIZE

2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size: 2021 VS 2028
2.2 Global Molecular Diagnostics Infectious Disease Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Molecular Diagnostics Infectious Disease Testing Players in Global Market
3.2 Top Global Molecular Diagnostics Infectious Disease Testing Companies Ranked by Revenue
3.3 Global Molecular Diagnostics Infectious Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics Infectious Disease Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Diagnostics Infectious Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics Infectious Disease Testing Players in Global Market
  3.6.1 List of Global Tier 1 Molecular Diagnostics Infectious Disease Testing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics Infectious Disease Testing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Molecular Diagnostics Infectious Disease Testing Market Size Markets, 2021 & 2028
  4.1.2 Bacterial Infectious Disease Testing
  4.1.3 Viral Infectious Disease Testing
  4.1.4 Parasitic Infectious Disease Testing
4.2 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue & Forecasts
  4.2.1 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2022
  4.2.2 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2023-2028
  4.2.3 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Molecular Diagnostics Infectious Disease Testing Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Laboratory Research
5.2 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue & Forecasts
  5.2.1 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2022
  5.2.2 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2023-2028
  5.2.3 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Molecular Diagnostics Infectious Disease Testing Market Size, 2021 & 2028
6.2 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue & Forecasts
  6.2.1 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2022
  6.2.2 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2023-2028
  6.2.3 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
  6.3.2 US Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.3.3 Canada Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.3.4 Mexico Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
  6.4.2 Germany Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.4.3 France Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.4.4 U.K. Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.4.5 Italy Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.4.6 Russia Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.4.7 Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.4.8 Benelux Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
  6.5.2 China Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.5.3 Japan Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.5.4 South Korea Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.5.5 Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.5.6 India Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
  6.6.2 Brazil Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.6.3 Argentina Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
  6.7.2 Turkey Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.7.3 Israel Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.7.4 Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
  6.7.5 UAE Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.1.4 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 BD
  7.2.1 BD Corporate Summary
  7.2.2 BD Business Overview
  7.2.3 BD Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.2.4 BD Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.2.5 BD Key News
7.3 bioM?rieux
  7.3.1 bioM?rieux Corporate Summary
  7.3.2 bioM?rieux Business Overview
  7.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.3.4 bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.3.5 bioM?rieux Key News
7.4 Thermo Fisher Scientific
  7.4.1 Thermo Fisher Scientific Corporate Summary
  7.4.2 Thermo Fisher Scientific Business Overview
  7.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.4.4 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.4.5 Thermo Fisher Scientific Key News
7.5 F. Hoffmann-La Roche
  7.5.1 F. Hoffmann-La Roche Corporate Summary
  7.5.2 F. Hoffmann-La Roche Business Overview
  7.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.5.4 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.5.5 F. Hoffmann-La Roche Key News
7.6 Siemens AG
  7.6.1 Siemens AG Corporate Summary
  7.6.2 Siemens AG Business Overview
  7.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.6.4 Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.6.5 Siemens AG Key News
7.7 Veridex
  7.7.1 Veridex Corporate Summary
  7.7.2 Veridex Business Overview
  7.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.7.4 Veridex Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.7.5 Veridex Key News
7.8 Luminex
  7.8.1 Luminex Corporate Summary
  7.8.2 Luminex Business Overview
  7.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.8.4 Luminex Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.8.5 Luminex Key News
7.9 GenMark Diagnostics
  7.9.1 GenMark Diagnostics Corporate Summary
  7.9.2 GenMark Diagnostics Business Overview
  7.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.9.4 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.9.5 GenMark Diagnostics Key News
7.10 Qiagen NV
  7.10.1 Qiagen NV Corporate Summary
  7.10.2 Qiagen NV Business Overview
  7.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.10.4 Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.10.5 Qiagen NV Key News
7.11 Genomix Biotech
  7.11.1 Genomix Biotech Corporate Summary
  7.11.2 Genomix Biotech Business Overview
  7.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.11.4 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.11.5 Genomix Biotech Key News
7.12 BioTheranostics
  7.12.1 BioTheranostics Corporate Summary
  7.12.2 BioTheranostics Business Overview
  7.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.12.4 BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.12.5 BioTheranostics Key News
7.13 GenMark Diagnostics
  7.13.1 GenMark Diagnostics Corporate Summary
  7.13.2 GenMark Diagnostics Business Overview
  7.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Major Product Offerings
  7.13.4 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
  7.13.5 GenMark Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Molecular Diagnostics Infectious Disease Testing Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics Infectious Disease Testing Market Drivers in Global Market
Table 3. Molecular Diagnostics Infectious Disease Testing Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics Infectious Disease Testing in Global Market
Table 5. Top Molecular Diagnostics Infectious Disease Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Molecular Diagnostics Infectious Disease Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Molecular Diagnostics Infectious Disease Testing Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics Infectious Disease Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics Infectious Disease Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Molecular Diagnostics Infectious Disease Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Molecular Diagnostics Infectious Disease Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Molecular Diagnostics Infectious Disease Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Molecular Diagnostics Infectious Disease Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 32. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 33. BD Corporate Summary
Table 34. BD Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 35. BD Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 36. bioM?rieux Corporate Summary
Table 37. bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 38. bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 41. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Corporate Summary
Table 43. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 44. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 45. Siemens AG Corporate Summary
Table 46. Siemens AG Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 47. Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 48. Veridex Corporate Summary
Table 49. Veridex Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 50. Veridex Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 51. Luminex Corporate Summary
Table 52. Luminex Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 53. Luminex Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 54. GenMark Diagnostics Corporate Summary
Table 55. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 56. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 57. Qiagen NV Corporate Summary
Table 58. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 59. Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 60. Genomix Biotech Corporate Summary
Table 61. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 62. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 63. BioTheranostics Corporate Summary
Table 64. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 65. BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)
Table 66. GenMark Diagnostics Corporate Summary
Table 67. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Offerings
Table 68. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Diagnostics Infectious Disease Testing Segment by Type in 2021
Figure 2. Molecular Diagnostics Infectious Disease Testing Segment by Application in 2021
Figure 3. Global Molecular Diagnostics Infectious Disease Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
Figure 8. By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 12. US Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 16. Germany Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 24. China Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Molecular Diagnostics Infectious Disease Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BD Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Veridex Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Luminex Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)